Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Liyan Y. Smeding"'
Autor:
Rhogerry Deshycka, Valentino Sudaryo, Nai-Jia Huang, Yushu Xie, Liyan Y. Smeding, Moon Kyung Choi, Hidde L. Ploegh, Harvey F. Lodish, Novalia Pishesha
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Low plasma levels of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) are associated with decreased low-density lipoprotein (LDL) cholesterol and a reduced risk of cardiovascular disease. PCSK9 binds to the epidermal growth factor-like repeat A (EGFA
Externí odkaz:
https://doaj.org/article/6e2cb9ebe8ff46288add6d9019ba5414
Autor:
Novalia Pishesha, Nicholas McCaul, Martín A. Rossotti, Weiyi Ma, Robine Janssen, Gualberto González-Sapienza, Liyan Y. Smeding, Tao Fang, William Pinney, Ashraful Islam, Yushu J. Xie, Harun R. Sugito, Thibault J. Harmand, Hidde L. Ploegh, Leif S. Ludwig
Publikováno v:
Nature Biomedical Engineering. 5:1389-1401
The association of autoimmune diseases with particular allellic products of the class-II major histocompatibility complex (MHCII) region implicates the presentation of the offending self-antigens to T cells. Because antigen-presenting cells are toler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ee1ee81ba3281036f5c9c51fe6fc495
https://doi.org/10.1038/s41551-021-00738-5
https://doi.org/10.1038/s41551-021-00738-5
Autor:
Harun R. Sugito, Novalia Pishesha, Yushu Xie, Nicholas McCaul, Liyan Y. Smeding, Tao Fang, Ashraful Islam, Robine Janssen, Thibault J. Harmand, William Pinney, Hidde L. Ploegh, Leif S. Ludwig, Weiyi Ma
The association of autoimmune diseases with particular allelic variants of Class II MHC (MHCII) products implicates presentation of the offending self-antigen(s) to T cells. Antigen presenting cells are tolerogenic when they encounter antigen under n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f377515d5135a6c1aa58d2c522a811b2
https://doi.org/10.21203/rs.3.rs-192181/v1
https://doi.org/10.21203/rs.3.rs-192181/v1
Autor:
Hidde L. Ploegh, Harvey F. Lodish, Moon Kyung Choi, Liyan Y. Smeding, Yushu Xie, Valentino Sudaryo, Novalia Pishesha, Rhogerry Deshycka, Nai-Jia Huang
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0259353 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
Low plasma levels of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) are associated with decreased low-density lipoprotein (LDL) cholesterol and a reduced risk of cardiovascular disease. PCSK9 binds to the epidermal growth factor-like repeat A (EGFA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49cead415ecbd7191fb0f5a2f2877bd
https://doaj.org/article/578e74400dc64fdb8e36d78c1909d017
https://doaj.org/article/578e74400dc64fdb8e36d78c1909d017
Autor:
Liyan Y. Smeding, Moon Kyung Choi, Yushu Xie, Rhogerry Deshycka, Hidde L. Ploegh, Valentino Sudaryo, Novalia Pishesha, Nai-Jia Huang, Harvey F. Lodish
Low plasma levels of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) are associated with decreased low-density lipoprotein (LDL) cholesterol and a reduced risk of cardiovascular disease. PCSK9 binds to the epidermal growth factor-like repeat A (EGFA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfbcfc85489bd41752e1528437a8d7d7
https://doi.org/10.1101/2020.11.02.364620
https://doi.org/10.1101/2020.11.02.364620